{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:20:47Z","timestamp":1790436047964,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22MC1940300"],"award-info":[{"award-number":["22MC1940300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012600","name":"ShanghaiTech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016983","name":"Shanghai Clinical Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jid.2026.01.009","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:14:43Z","timestamp":1769213683000},"page":"1896-1905.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Botulinum neurotoxin type A1 alleviates bleomycin-induced skin fibrosis by inhibiting phosphatidylinositol 3-kinase\u2013protein kinase B (PI3K-Akt) pathway and associated cell cycle and proliferation"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2534-0896","authenticated-orcid":false,"given":"Fangzhou","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4341-7426","authenticated-orcid":false,"given":"Yun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-465X","authenticated-orcid":false,"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.01.009_bib1","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jid.2019.02.020","article-title":"Bone morphogenetic Protein-6 inhibits fibrogenesis in scleroderma offering treatment options for fibrotic skin disease","volume":"139","author":"Arndt","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.01.009_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/ken405","article-title":"Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis","volume":"48","author":"Badea","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2026.01.009_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/691314","article-title":"Successful treatment of hemifacial myokymia and dystonia associated to linear scleroderma \"en coup de sabre\" with repeated Botox injections","volume":"2012","author":"Ca\u00f1as","year":"2012","journal-title":"Case Rep Med"},{"key":"10.1016\/j.jid.2026.01.009_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/jpm14080872","article-title":"Advances in the management of localized scleroderma: a systematic review of laser therapy and injectable filler approaches","volume":"14","author":"Cassalia","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.jid.2026.01.009_bib5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41419-021-04325-z","article-title":"Activation of G protein coupled estrogen receptor prevents chemotherapy-induced intestinal mucositis by inhibiting the DNA damage in crypt cell in an extracellular signal-regulated kinase 1- and 2- dependent manner","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2026.01.009_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5334\/tohm.410","article-title":"Characterization and treatment of unilateral facial muscle spasm in linear scleroderma: a case report","volume":"8","author":"Danisi","year":"2018","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.jid.2026.01.009_bib7","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/cancers14071652","article-title":"PI3K\/AKT signaling tips the balance of cytoskeletal forces for cancer progression","volume":"14","author":"Deng","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2026.01.009_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mib.2012.05.012","article-title":"Clinical applications of botulinum toxin","volume":"15","author":"Dressler","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.jid.2026.01.009_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.jid.2026.01.009_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.01.009_bib11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment","volume":"10","author":"Harjunp\u00e4\u00e4","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.01.009_bib12","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.7150\/ijbs.77649","article-title":"Enhancement of zyxin promotes skin fibrosis by regulating FAK\/PI3K\/AKT and TGF-\u03b2 signaling pathways via integrins","volume":"19","author":"Huang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jid.2026.01.009_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.berh.2016.04.001","article-title":"Raynaud's phenomenon","volume":"30","author":"Hughes","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jid.2026.01.009_bib14","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s12276-024-01366-0","article-title":"GRIM-19-mediated induction of mitochondrial STAT3 alleviates systemic sclerosis by inhibiting fibrosis and Th2\/Th17 cells","volume":"56","author":"Jeong","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jid.2026.01.009_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-021-04267-8","article-title":"Human blastoids model blastocyst development and implantation","volume":"601","author":"Kagawa","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jid.2026.01.009_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archneur.57.4.576","article-title":"Hemimasticatory spasm associated with localized scleroderma and facial hemiatrophy","volume":"57","author":"Kim","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jid.2026.01.009_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1529-8019.2012.01479.x","article-title":"Localized scleroderma","volume":"25","author":"Kreuter","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2026.01.009_bib18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41598-024-52359-y","article-title":"A MEK inhibitor arrests the cell cycle of human conjunctival fibroblasts and improves the outcome of glaucoma filtration surgery","volume":"14","author":"Lee","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2026.01.009_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/jocd.13842","article-title":"Botulinum toxin type A attenuates hypertrophic scar formation via the inhibition of TGF-\u03b21\/Smad and ERK pathways","volume":"20","author":"Li","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jid.2026.01.009_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneurol.2010.149","article-title":"Use of botulinum toxin in the neurology clinic","volume":"6","author":"Lim","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jid.2026.01.009_bib21","doi-asserted-by":"crossref","first-page":"171e","DOI":"10.1097\/PRS.0000000000011467","article-title":"Tracking fat grafts by magnetic resonance imaging: a comparative study of adolescent and adult patients with stable localized scleroderma","volume":"155","author":"Ma","year":"2025","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jid.2026.01.009_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jid.2026.01.009_bib23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1600-0412.2011.01183.x","article-title":"Botulinum toxin type A for treatment of dyspareunia caused by localized scleroderma","volume":"90","author":"Mousty","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jid.2026.01.009_bib24","article-title":"Morphea: the 2023 update","volume":"10","author":"Papara","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2026.01.009_bib25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2018.04.006","article-title":"Blocking neuronal signaling to immune cells treats streptococcal invasive infection","volume":"173","author":"Pinho-Ribeiro","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jid.2026.01.009_bib26","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","article-title":"Role of PI3K\/Akt signaling pathway in cardiac fibrosis","volume":"476","author":"Qin","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jid.2026.01.009_bib27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/DSS.0000000000000812","article-title":"Improvement of \"en coup de sabre\" morphea and associated headaches with botulinum toxin injections","volume":"42","author":"Rimoin","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jid.2026.01.009_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jid.2026.01.009_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1573397117666211012105611","article-title":"Evaluation of botulinum toxin type A and its potential effect on exacerbated Raynaud's phenomenon in hospitalized scleroderma patients","volume":"18","author":"Seyedmardani","year":"2022","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.jid.2026.01.009_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/ijd.15811","article-title":"Localized scleroderma: actual insights and new biomarkers","volume":"61","author":"Snarskaya","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2026.01.009_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard.2007.077446","article-title":"High-dose cyclophosphamide without stem cell rescue in scleroderma","volume":"67","author":"Tehlirian","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2026.01.009_bib32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3389\/fimmu.2019.00908","article-title":"Immunopathogenesis of pediatric localized scleroderma","volume":"10","author":"Torok","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2026.01.009_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jid.2026.01.009_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin Cancer Biol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:01:12Z","timestamp":1785895272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022202X26000308"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.01.009","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum neurotoxin type A1 alleviates bleomycin-induced skin fibrosis by inhibiting phosphatidylinositol 3-kinase\u2013protein kinase B (PI3K-Akt) pathway and associated cell cycle and proliferation","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Investigative Dermatology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}